Patents by Inventor Maria Garcia

Maria Garcia has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • PGC-1?-modulating peptides
    Patent number: 9266921
    Abstract: Peptides of general formula (I): R1—Wn—Xm-AA1-AA2-AA3-AA4-AA5-AA6-Yp—Zq—R2 their stereoisomers, mixtures thereof and/or their cosmetically or pharmaceutically acceptable salts, a preparation process, cosmetic or pharmaceutical compositions which contain them and their use in the treatment and/or care of conditions, disorders and/or diseases which improve or are prevented by PGC-1? modulation.
    Type: Grant
    Filed: March 23, 2012
    Date of Patent: February 23, 2016
    Assignee: Lipotec, S.A.
    Inventors: José María García Antón, Nuria Almiñana Domenech, Antonio Vicente Ferrer Montiel
  • NOVEL COMPOUNDS AS DUAL INHIBITORS OF PHOSPHODIESTERASES AND HISTONE DEACETYLASES
    Publication number: 20160002246
    Abstract: It relates to certain compounds having a polycyclic structure and a hydroxamic acid moiety, wherein the polycyclic structure comprises at least three ring systems, wherein one ring system is a polycyclic ring system comprising from 2 to 4 rings; at least one ring is an aromatic ring; and wherein the structure comprises at least 3 nitrogen atoms and 1 oxygen atom. It also relates to a process for their preparation, as well as to pharmaceutical compositions containing them, and to their use in medicine, in particular in the treatment and/or prevention of neurological disorders coursing with a cognition deficit or impairment, or neurodegenerative diseases.
    Type: Application
    Filed: February 27, 2014
    Publication date: January 7, 2016
    Inventors: Maria Del Mar CUADRADO TEJEDOR, Rafael FRANCO FERNÁNDEZ, Ana Maria GARCÍA OSTA, Julen OYARZABAL SANTAMARINA, Maria Obdulia RABAL GRACIA
  • Tissue ligation devices and controls therefor
    Patent number: 9198664
    Abstract: Described here are devices for closing one or more tissues, and handles for controlling these devices. Generally, the devices described here comprise a snare loop assembly, wherein the snare loop assembly comprises a snare and a suture loop, and a handle for controlling the snare loop assembly. In some variations the snare loop assembly may comprise a retention member that may releasably connect the suture loop to the snare. In other variations the devices comprise one or more force-reducing suture locks to help prevent the suture loop from inadvertently disengaging from the snare loop assembly. In still other variations, the excess-suture management features. The handles described here may be configured to remove excess suture from a suture loop, and may also be configured to release the suture loop from the snare loop assembly.
    Type: Grant
    Filed: April 1, 2010
    Date of Patent: December 1, 2015
    Assignee: SentreHEART, Inc.
    Inventors: Gregory W. Fung, Russell A. Seiber, Eduardo Sager, Gary H. Miller, Maria Garcia, Ryan Douglas Helmuth, Arnold M. Escano, Douglas Todd Ellison, William E. Cohn
  • Gravity-Based Foundation System for the Installation of Offshore Wind Turbines and Method for the Installation of an Offshore Wind Turbine Foundation System
    Publication number: 20150240442
    Abstract: The present invention relates to a gravity-based foundation system for offshore wind turbine installation which enables the transport, anchoring and subsequent refloating of the structure-wind turbine assembly once anchored, giving great versatility to the solution with regard to the uncertainties associated with the installation and terrain response in the short and long term, as well as the method for installing the preceding gravity-based foundation system.
    Type: Application
    Filed: May 28, 2013
    Publication date: August 27, 2015
    Inventors: Jose Maria Garcia-Valdecasas Bernal, Rafael Molina Sanchez, Miguel Angel Cabrerizo Morales, Javier Ivars Salom
  • Peptides useful in the treatment and care of the skin and mucous membranes and their use in cosmetic or pharmaceutical compositions
    Patent number: 9067967
    Abstract: Peptides of general formula (I), their stereoisomers, mixtures thereof and/or their cosmetically or pharmaceutically acceptable salts, a preparation process, cosmetic or pharmaceutical compositions which contain them and their use for the treatment and/or care of conditions, disorders and/or diseases of the skin and/or mucous membranes.
    Type: Grant
    Filed: March 23, 2012
    Date of Patent: June 30, 2015
    Assignee: LIPOTEC, S.A.
    Inventors: José María García Antón, Nuria Almiñana Domenech, Antonio Vicente Ferrer Montiel
  • COMPOUNDS WHICH INHIBIT NEURONAL EXOCYTOSIS
    Publication number: 20150140046
    Abstract: Compounds of general formula (I): R1-Wn-Xm-AA1-AA2-AA3-AA4-AA5-AA6-AA7-AA8-AA9-Yp-Zq-R2 (I) their stereoisomers, mixtures thereof and/or their cosmetically or pharmaceutically acceptable salts, preparation processes, cosmetic or pharmaceutical compositions which contain them and their use in medicine, particularly in the treatment and/or prevention of pain, inflammation, itching, neurological, compulsive and/or neuropsychiatric diseases and/or disorders and in processes of treatment and/or care of the skin, hair and/or mucous membranes mediated by neuronal exocytosis.
    Type: Application
    Filed: April 12, 2013
    Publication date: May 21, 2015
    Inventors: Antonio Vicente Ferrer Montiel, Gregorio Fernández Ballester, José María García Antón, Cristina Carreño Serraïma, Núria Almiñana Doménech, Raquel Delgado González
  • CROSSTALK REDUCTION IN SIGNAL LINES BY CROSSTALK INTRODUCTION
    Publication number: 20150130553
    Abstract: A circuit component is described herein. The circuit component includes a first signal line to propagate in a first direction and a second signal line to propagate a second direction. The circuit component includes a region to introduce crosstalk within the region that reduces another crosstalk generated at a location remote from the region based on a change in propagation direction of the first signal line and second signal line.
    Type: Application
    Filed: November 14, 2013
    Publication date: May 14, 2015
    Inventors: Raul Enriquez Shibayama, Maria Garcia Garcia de Leon, Kai Xiao, Beom-Taek Lee, Carlos Lizalde Moreno
  • COMPOUNDS FOR THE TREATMENT AND/OR CARE OF THE SKIN AND/OR MUCOUS MEMBRANES AND THEIR USE IN COSMETIC OR PHARMACEUTICAL COMPOSITIONS
    Publication number: 20150104485
    Abstract: Compounds of general formula (I): Ri—Wn—Xm-AAi-AA2-AA3-AA4-AA5-AA6-Yp—Zq—R2 (I) their stereoisomers, mixtures thereof and/or their cosmetically or pharmaceutically acceptable salts, preparation processes, cosmetic and/or pharmaceutical compositions which contain them and their use in medicine, particularly in the treatment and/or prevention of pain, inflammation, itching, pigmentation disorders and angiogenic skin disorders, and in processes of treatment and/or care of the skin and/or mucous membranes.
    Type: Application
    Filed: April 16, 2013
    Publication date: April 16, 2015
    Applicant: LUBRIZOL ADVANCED MATERIALS, INC.
    Inventors: Jose Maria Garcia Anton, Antonio Vicente Ferrer Montiel, Cristina Carreño Serraïma, Raquel Delgado González, Juan Cebrián Puche
  • COMPOUNDS WHICH INHIBIT NEURONAL EXOCYTOSIS
    Publication number: 20150098989
    Abstract: Compounds of general formula (I): R1—Wn—Xm-AA1-AA2-AA3-AA4-AA5-AA6-AA7-Yp—Zq—R2, their stereoisomers, mixtures thereof and/or their cosmetically or pharmaceutically acceptable salts, preparation processes, cosmetic or pharmaceutical compositions which contain them and their use in medicine, particularly in the treatment and/or prevention of pain, inflammation, itching, neurological, compulsive and/or neuropsychiatric diseases and/or disorders and in processes of treatment and/or care of the skin, hair and/or mucous membranes mediated by neuronal exocytosis.
    Type: Application
    Filed: April 12, 2013
    Publication date: April 9, 2015
    Inventors: Antonio Vicente Ferrer Montiel, Gregorio Fernández Ballester, José María García Antón, Cristina Carreño Serraïma, Núria Almiñana Doménech, Raquel Delgado González
  • COMPOUNDS WHICH INHIBIT NEURONAL EXOCYTOSIS
    Publication number: 20150071974
    Abstract: Compounds of general formula (I): R1—Wn—Xm-AA1-AA2-AA3-AA4-AA5-AA6-Yp—Zq—R2 (I) their stereoisomers, mixtures thereof, their cosmetically or pharmaceutically acceptable salts and/or its functionally equivalent variants, preparation processes, cosmetic or pharmaceutical compositions which contain them and their use in medicine, particularly in the treatment and/or prevention of pain, inflammation, itching, neurological, compulsive and/or neuropsychiatric diseases and/or disorders and in processes of treatment and/or care of the skin, hair and/or mucous membranes mediated by neuronal exocytosis.
    Type: Application
    Filed: April 12, 2013
    Publication date: March 12, 2015
    Inventors: Antonio Vicente Ferrer Montiel, Gregorio Fernández Ballester, José Maria García Antón, Cristina Carreño Serraïma, Núria Almiñana Doménech, Raquel Delgado González
  • PEPTIDES WHICH INHIBIT ACTIVATED RECEPTORS AND THEIR USE IN COSMETIC OR PHARMACEUTICAL COMPOSITIONS
    Publication number: 20140322307
    Abstract: The present invention refers to a peptide of general formula (I) R1-Wn-Xm-AA1-AA2-AA3-AA4-AA5-AA6-Yp-Zq-R2, cosmetic compositions which comprises said peptide, method of preparation of said peptides and its use in the treatment and/or prevention of itching, inflammation, pain, diseases and/or disorders of the respiratory airways.
    Type: Application
    Filed: October 31, 2012
    Publication date: October 30, 2014
    Inventors: Antonio Vicente Ferrer Montiel, José María García Antón, Raquel Delgado González
  • Process for the treatment of sodium-containing heavy residues and fuel so obtained
    Patent number: 8815084
    Abstract: Process for the removal of sodium from sodium-containing heavy fractions from a process for the combined production of styrene and propylene oxide comprising admixing an aqueous solution of an organic carboxylic acid to the heavy fraction at a temperature comprised between 20° C. and 100° C., and separation of the organic phase from the aqueous phase, wherein the organic phase contains less than 0.5% by weight of polymeric solids. The obtained organic phase has low viscosity and ash content and can be used directly as a fuel.
    Type: Grant
    Filed: October 29, 2004
    Date of Patent: August 26, 2014
    Inventors: Pilar de Frutos Escrig, Eva Maria Garcia Biosca
  • PEPTIDES USEFUL IN THE TREATMENT AND CARE OF THE SKIN AND MUCOUS MEMBRANES AND THEIR USE IN COSMETIC OR PHARMACEUTICAL COMPOSITIONS
    Publication number: 20140120141
    Abstract: Peptides of general formula (I), their stereoisomers, mixtures thereof and/or their cosmetically or pharmaceutically acceptable salts, a preparation process, cosmetic or pharmaceutical compositions which contain them and their use for the treatment and/or care of conditions, disorders and/or diseases of the skin and/or mucous membranes.
    Type: Application
    Filed: March 23, 2012
    Publication date: May 1, 2014
    Applicant: LIPOTEC S.A.
    Inventors: José María García Antón, Nuria Almiñana Domenech, Antonio Vicente Ferrer Montiel
  • ACLIDINIUM FOR USE IN IMPROVING THE QUALITY OF SLEEP IN RESPIRATORY PATENTS
    Publication number: 20140100246
    Abstract: The present invention provides aclidinium or any of its steroisomers or mixture of stereoisomers, or a pharmaceutically acceptable salt or solvate thereof, for improving the quality of sleep in respiratory patients.
    Type: Application
    Filed: April 11, 2012
    Publication date: April 10, 2014
    Inventors: Esther Maria Garcia Gil, Gonzalo Miquel Serra, Maria Sala Peinado
  • PGC-1ALPHA-MODULATING PEPTIDES
    Publication number: 20140086981
    Abstract: Peptides of general formula (I): R1—Wn—Xm-AA1-AA2-AA3-AA4-AA5-AA6-Yp—Zq—R2 their stereoisomers, mixtures thereof and/or their cosmetically or pharmaceutically acceptable salts, a preparation process, cosmetic or pharmaceutical compositions which contain them and their use in the treatment and/or care of conditions, disorders and/or diseases which improve or are prevented by PGC-1? modulation.
    Type: Application
    Filed: March 23, 2012
    Publication date: March 27, 2014
    Inventors: José María García Antón, Nuria Almiñana Domenech, Antonio Vicente Ferrer Montiel
  • Revaluation of aqueous waste streams in the propylene oxide/styrene co-production process
    Patent number: 8679343
    Abstract: The present disclosure describes a method for the revaluation of aqueous waste streams generated in the propylene oxide and styrene co-production processes. In particular, it discloses a method of reducing the organic contaminant load from a highly contaminated aqueous stream and recovery from said stream of organic compounds that may be recirculated or used as fuel in the co-generation of energy, and which comprises: acidification of said aqueous stream with inorganic acid at a pH less than 4.5; separation of the two resulting phases at a temperature greater than 40° C.; washing of the organic phase produced in the previous step with an aqueous solution of excess acid and separation of the two resulting phases.
    Type: Grant
    Filed: May 14, 2008
    Date of Patent: March 25, 2014
    Assignee: Repsol S.A.
    Inventors: Eva Maria Garcia Biosca, Ignacio Rivera Sarmiento, Belén Mula Andres, Jorge Rodriguez Bustamante, Maria Pilar De Frutos Escrig
  • Metal complexes; use thereof for the preparation of compositions for agricultural use
    Patent number: 8652231
    Abstract: Novel metal complexes useful in the area of agriculture, notably as agents for treating metal deficiency. The novel metal complexes comprise at least one metal selected from the metal trace elements essential for the development of plants, at least one first ligand selected from the lignosulfonates, and derivatives thereof, and at least one second ligand selected from the multidentate organic ligands.
    Type: Grant
    Filed: October 15, 2009
    Date of Patent: February 18, 2014
    Assignee: Timac Argo International
    Inventors: Marta Fuentes, Roberto Baigorri, Eva Bacaicoa, Jose Maria Garcia-Mina, Jean-Claude Yvin
  • Imidazolothiadiazoles for use as protein kinase inhibitors
    Patent number: 8563550
    Abstract: There is provided compounds of formula (I), wherein Z, M, R1, X, R2, R3 and B have meanings given in the description, and pharmaceutically-acceptable esters, amides, solvates or salts thereof, which compounds are useful in the treatment of diseases in which inhibition of a protein kinase (e.g. a PIM family kinase or PI3-K) is desired and/or required, and particularly in the treatment of cancer.
    Type: Grant
    Filed: September 29, 2008
    Date of Patent: October 22, 2013
    Inventors: Paolo Pevarello, Ana Maria Garcia Collazo, Ana Belen Garcia Garcia
  • Automobile windshield wiper system having direct drive drum and cable assembly
    Patent number: 8522392
    Abstract: A wiper system having an electric motor operatively associated with a primary pivot shaft assembly. Also included is a secondary pivot shaft assembly. A first windshield wiper is coupled to the primary pivot shaft assembly, and a second windshield wiper is coupled to the secondary pivot shaft assembly. The system includes a cable assembly having at least one cable operatively associated with the primary pivot shaft assembly and the secondary pivot shaft assembly, wherein the electric motor is capable of rotating the primary pivot shaft assembly and the first windshield wiper, wherein rotation of the primary pivot shaft assembly generates tension in the at least one cable, and wherein the at least one cable tension generates rotation of the secondary pivot shaft assembly and the second windshield wiper.
    Type: Grant
    Filed: August 3, 2009
    Date of Patent: September 3, 2013
    Assignee: Ford Global Technologies, LLC
    Inventors: Jose Maria Garcia Crespo, Heather M. Flores, Andre Sykula, Bradley Napier Doman
  • OXYGEN-ABSORBING COMPOUND ENCAPSULATED IN A SILICA MATRIX AND METHOD FOR THE PRODUCTION THEREOF
    Publication number: 20130207042
    Abstract: This disclosure refers to the fabrication of an active oxygen-absorbing compound composed of a sodium erythorbate and a non-organic salt of a transition metal encapsulated through the sol-gel method in a silica matrix. This compound can be part of the package's structure for oxidation-sensitive products or contained in the surrounding atmosphere to decrease the oxygen concentration. This application describes the method for the fabrication of the oxygen-absorber, as well as its encapsulation and incorporation in polymeric matrixes.
    Type: Application
    Filed: March 18, 2011
    Publication date: August 15, 2013
    Inventors: Ronald Vicente Joven Pineda, Jorge Alberto Medina Perilla, Angela Maria Garcia Mora, Andrea Marcela Arias Herrera